Pharmacy substitution of Singulair for a generic — for France
In many countries, the pharmacist may dispense an authorised generic of Singulair (Montelukast) instead of the branded version, often automatically or unless the prescriber explicitly objects. The substitution is regulated, the active ingredient stays the same, and the practical implications at 4mg, 5mg, 10mg mostly come down to price, manufacturer and tablet appearance.
France context
Substitution rules in France are set by ANSM (Agence nationale de sécurité du médicament et des produits de santé) and applied at dispensing. Pharmacies in France are independent owner-pharmacist businesses, marked by the iconic green cross. The pharmacist is a routine medical consultant for minor ailments and triage. For Singulair, this typically means the pharmacist may swap to an authorised generic of Montelukast unless the prescriber has marked the prescription "do not substitute"; the clinical effect at 4mg, 5mg, 10mg stays the same and the price difference in EUR usually goes to the patient's benefit.
- Regulator
- ANSM (Agence nationale de sécurité du médicament et des produits de santé)
- Currency
- EUR
How substitution works
When the prescription specifies Singulair, the pharmacist checks local rules: in some jurisdictions automatic substitution to the cheapest authorised generic is the default unless the doctor writes "do not substitute"; in others, the patient must explicitly accept or refuse the swap. The active ingredient Montelukast stays the same, the strength stays the same (4mg, 5mg, 10mg), and the clinical effect is, on average, identical. Montelukast selectively blocks the CysLT1 receptor, which mediates the action of leukotrienes C4, D4 and E4 — proinflammatory mediators released by mast cells and eosinophils.
What you can ask
According to local pharmacy practice, patients can usually ask for the brand even when the generic is offered, accepting the price difference. They can also ask the pharmacist about the specific generic being dispensed — manufacturer, country of production and excipients — particularly relevant for users with known sensitivities. The pharmacist is the right person to clarify the substitution rules in your jurisdiction.
Frequently asked questions
Why is the pharmacy giving me a different brand of Singulair? ▾
The pharmacy is dispensing an authorised generic of Montelukast that is bioequivalent to Singulair. Local substitution rules and the price difference are the usual reasons. The active substance and clinical effect at 4mg, 5mg, 10mg are the same.
Can I refuse the generic and keep getting Singulair? ▾
Usually yes — most jurisdictions let patients pay the price difference and continue with the brand. The pharmacist confirms whether refusing substitution is allowed locally and what the cost gap is.
Pharmacy substitution of Singulair for a generic in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
- CanadaHealth Canada
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.